NextUp: The Philly biotech company developing an in vivo approach to CAR T-Cell therapy

Posted on May 28, 2021 — Jessica Jones Gupta

Interius BioTherapeutics just raised $76 million in seed funding to advance their clinical testing. Interius is a Philadelphia-based preclinical stage biotechnology company initially focused on treating hematologic malignancies by leveraging its novel gene delivery platform to generate CAR T cells directly in vivo. Founded by Saar Gill, a lead physician-scientist at the University of Pennsylvania’s…

Penn’s gene therapy program has signed a 150,000 sq ft lease at a former GlaxoSmithKline property in King of Prussia

Posted on May 26, 2021 — Jessica Jones Gupta

“The Penn transaction is an indicator that the entire region is benefiting from the research being done in our world-renowned institutions.” Read More in the Philadelphia Inquirer

Webinar Recording: Tips from Early Stage Investors

Posted on May 25, 2021 — Jessica Jones Gupta

Gain insight from Venture Capitalists who focus on investing in early stage University startups. Recorded on May 19, 2021. Three VCs discuss the lessons learned from early stage investing using personal real-world examples. This talk features: Manny Stockman, Principle, Osage University Partners Brett Topche, Managing Director, Red and Blue Ventures Andrea Kalmans, Principal, Lontra Ventures,…

IQ Motion Control Is Democratizing Advanced Servo Capabilities

Posted on — Jessica Jones Gupta

Former I-Corps participant, and current PennovationWorks tenant, IQ Motion Control announced the launch of their newest line of servo motors, the Fortiq BLS42. It is built to maximize torque and speed output, while minimizing motor vibration and footprint. Read More in the Pennovation Works blog

Penn cell and gene therapy spinout Interius Biotherapeutics raises $76 million

Posted on May 18, 2021 — Jessica Jones Gupta

A two-year-old Philadelphia gene therapy company spun out of the University of Pennsylvania has raised $76 million in one of the largest private stock sales by a local life sciences company this year. Interius Biotherapeutics was co-founded by Dr. Saar Gill, a Penn Medicine hematologist/oncologist and expert in the field of immunotherapy, and longtime life sciences…

Rapid COVID-19 diagnostic test delivers accurate results within 4 minutes

Posted on — Jessica Jones Gupta

The low-cost biosensor test developed by Penn Medicine could extend COVID-19 testing with 90% accuracy to remote and disadvantaged areas. A paper published in Matter details the fast and inexpensive diagnostic test, called RAPID 1.0 (Real-time Accurate Portable Impedimetric Detection prototype 1.0). Compared to existing methods for COVID-19 detection, RAPID is inexpensive and highly scalable,…

Cellicon Valley – Commercialization of CAR-T technology webinar

Posted on May 17, 2021 — Jessica Jones Gupta

As home to the first FDA-approved cell and gene therapies, Penn Medicine and Children’s Hospital of Philadelphia are international leaders who have helped propel Philadelphia into Cellicon Valley, with Penn ranking 1st among global universities for CAR-T cell patents according to Nature. CAR T represents a turning point in the history of human medicine, a…

Passage Bio wins the Life Sciences PA Deal of the Year Award

Posted on May 12, 2021 — Jessica Jones Gupta

Life Sciences PA has announced that Passage Bio is the recipient of their 2021 Deal of the Year Award.  This award, and several others, will be given out at their Annual Ceremony which this year is a Tailgate at Citizens Bank Park on Wed, May 26.  Register here. 

Advanced Therapies Intensive for PSOM Researchers

Posted on May 11, 2021 — Jessica Jones Gupta

The University of Pennsylvania is partnering with King’s Health Partners, a branch of King’s College London, to provide a research and training experience. Join us for a one-week intensive led by Dr. Emma Meagher focusing on immersion into the advanced therapies experience. Penn and CHOP participants will have the opportunity to learn from their peers…

Baxter Young Investigator Awards 2021

Posted on — Jessica Jones Gupta

Applications are now being accepted for the 2021 Baxter Young Investigator Awards (BYIA). The BYIA is an annual program sponsored by Baxter to support and promote innovative research applicable to the development of critical therapies and clinical diagnostics. All applicants must be currently enrolled graduate students or postdoctoral fellows in North, Central, or South America…